Effects of ezetimibe on postprandial hyperlipidaemia and hyperglycemia in Japanese hyperlipidemic patients; Double-blinded crossover randomized clinical trial.

Trial Profile

Effects of ezetimibe on postprandial hyperlipidaemia and hyperglycemia in Japanese hyperlipidemic patients; Double-blinded crossover randomized clinical trial.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Jun 2011

At a glance

  • Drugs Ezetimibe (Primary)
  • Indications Hyperlipidaemia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 Jun 2011 Results presented at the 71st Annual Scientific Sessions of the American Diabetes Association.
    • 22 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan ecord.
    • 13 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top